Amwill Health Care Limited has approved an aggregate investment of up to ₹3 crore in two SEBI-registered Alternative Investment Fund (AIF) schemes. The decision, taken by the company's Investment Committee on September 25, 2026, aims to support its long-term growth strategy and operational objectives.

The investments will be funded entirely from the company's internal accruals. The disclosure was made to the Bombay Stock Exchange (BSE) under Regulation 30 of the SEBI Listing Regulations, read with the SEBI Master Circular dated January 30, 2026. The transaction does not involve any related party dealings.

Investment breakdown

The Investment Committee approved two distinct subscriptions, each capped at ₹1.50 crore. The first allocation is directed toward the Vivriti Vihaan Trust, while the second targets the Neo Income Plus Fund III. Both entities are registered with the Securities and Exchange Board of India (SEBI).

The company stated that the subscription to Neo Income Plus Fund III units is proposed to be made in the ensuing months. The move reflects a strategic deployment of surplus capital into structured credit and income-generating instruments rather than traditional equity or debt markets.

Regulatory compliance and governance

This approval follows a preliminary sanction granted by the Investment Committee during its meeting on August 8, 2026. The final execution approval was formalized at the September 25, 2026 meeting. The disclosure ensures transparency regarding the utilization of internal funds for external financial instruments.

The filing confirms that these transactions are arm's length and do not constitute related party transactions, adhering to standard corporate governance norms. The details of this disclosure are available on the company's official website.

Amwill Health Care Limited concluded its 9th Annual General Meeting on August 14, 2026, with shareholders approving key governance resolutions and the company’s financial statements for FY26. The meeting was conducted through Video Conferencing or Other Audio-Visual Means in compliance with Ministry of Corporate Affairs and Securities and Exchange Board of India regulations. Twenty members were present to establish the requisite quorum.

Key Resolutions Approved

The primary business transacted at the meeting included the adoption of the audited financial statements for the fiscal year ended March 31, 2026, along with the reports of the Directors and Auditors. Shareholders also approved the declaration of a final dividend on equity shares for the same period. The Secretarial Audit Report for FY26 contained no qualifications, reservations, adverse remarks, or observations.

Board Appointments

Ms. Sapna Parmar was reappointed as a Non-Executive Director after retiring by rotation. In a special resolution, shareholders approved the reappointment of Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors. As Mr. Tarun Gandhi had an interest in these items, Independent Director Mr. Man Singh Gilundia chaired the proceedings for these specific resolutions before Mr. Gandhi resumed the chair.

Meeting Proceedings

Mr. Tarun Gandhi, Managing Director, presided over the meeting and provided an overview of the company’s financial performance and future outlook. Mr. Anand Gandhi, also a Managing Director, addressed members on operational performance and sales and marketing strategies. Ms. Anshu Anshuman, Company Secretary and Compliance Officer, coordinated the proceedings and confirmed the presence of statutory and secretarial auditors.

Independent Director Mr. Vasanth Kumar was unable to attend due to prior commitments but authorized Ms. Sapna Parmar to respond to queries related to the Nomination and Remuneration Committee. The remote e-voting facility, managed by National Depository Services Limited, remained open for 15 minutes after the conclusion of the meeting for shareholders who had not cast their votes remotely.